 |
 |
Professor Steven Teitelbaum, past president of the Federation of American Societies for Experimental Biology, says the promise of this research is that patients could use their own cells to ward off serious illnesses. Stem Cells Hold Great Promise In the hopes of alleviating diseases such as Alzheimer's, diabetes, and Parkinson's, University scientists urge Missouri legislators not to ban the research procedure "somatic cell nuclear transfer." This is the most important issue for medical research and future patient care that I can recall in the 44 years I've been a Missourian!" says research scientist and physician Steven L. Teitelbaum, who left Brooklyn in 1960 to enroll in the Washington University School of Medicine. What Teitelbaum, the Wilma and Roswell Messing Professor of Pathology and Immunology, cares about so deeply are the vast possibilities for healing diseases like Parkinson's and diabetes-cures that could result from research on early-stage stem cells (sometimes referred to as embryonic stem cells). Throughout the State of Missouri and beyond, scientists, research institutions, patient-advocacy groups, health-care organizations, and individuals strongly support early-stage stem-cell research. Unfortunately, a group of conservative political and religious leaders are attempting to criminalize such research in Missouri, specifically a research procedure to derive early-stage stem cells called "somatic cell nuclear transfer," or SCNT. ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn